AI-generated summary
The authors randomized 74 hospitalized patients with acute leukemia to bright white light therapy (30 minutes each morning) or a control group and tracked symptoms over time. They report statistically significant differences at weeks 1, 2, and 3, with the light group reporting less anxiety, sleep disturbance, and fatigue at week 2, while distress and depression showed little difference. The trial was nonblinded, so results should be interpreted with that limitation in mind.
- Participants
- 74
- Who or what was studied
- Hospitalized adults with acute leukemia at a 24-bed acute leukemia unit in a cancer hospital in the midwestern United States
- Limits stated in the abstract
- The trial was nonblinded, and the abstract reports that only 11 participants planned to use the therapy in the future.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ons.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Anxiety, Statistical significance, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.